| A Study of ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus (NCT07619157) | Ono Pharmaceutical Co., Ltd. | 2026-06-02 |
| Study of GS-2426 in Participants With Advanced Solid Tumors (NCT07601243) | Gilead Sciences | 2026-06-02 |
| A Study to Evaluate the Safety and Effect of TO-O-1007 Intravitreal Implant in Subjects With Geographic Atrophy (NCT07668804) | Theratocular Biotek Co. | 2026-06-02 |
| A Phase I Study of SHR-3836 in Patients With Multiple Myeloma (NCT07490613) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2026-06-02 |
| A Phase I Study of JSKN021 in Advanced Solid Tumors (NCT07617727) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2026-06-02 |
| A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis (NCT07604324) | Novartis Pharmaceuticals | 2026-06-02 |
| Study to Evaluate the Safety and Tolerability of AD-NP1 in Healthy Human Adult Volunteers (NCT07762001) | Arjun Deb, MD | 2026-06-02 |
| STEM CELL MOBILIZATION WITH HIGH-DOSE PLERIXAFOR IN PATIENTS WITH SICKLE CELL DISEASE (NCT07341022) | Hospital Israelita Albert Einstein | 2026-06-01 |
| EGEN-5784 Porcine Liver With the Metra® ELC Device (NCT07429838) | eGenesis, INC | 2026-06-01 |
| Immunity and Safety of Covid-19 Synthetic Minigene Vaccine (NCT04276896) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment (NCT07550634) | MindRank AI Ltd | 2026-06-01 |
| Biological, Radiographic and Clinical Evaluation of Various Inter-Visit Root Canal Dressings in Retreatment Cases (NCT07641933) | Ain Shams University | 2026-06-01 |
| Development of Fluorescent Lectin Tracers With Dedicated Technology for in Vivo Detection of Esophageal Dysplasia in Barrett Patients (NCT07643727) | University Medical Center Groningen | 2026-06-01 |
| Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke) (NCT07635758) | Chinese PLA General Hospital | 2026-06-01 |
| CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors (NCT07297160) | Baylor College of Medicine | 2026-06-01 |
| NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL (NCT05277753) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil (NCT07518121) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2026-06-01 |
| A Study to Evaluate the Safety and Pharmacokinetics of AD-231 Compared to Coadministration of AD-231A, AD-231D and AD-231C (NCT07590167) | Addpharma Inc. | 2026-06-01 |
| HER2 Vaccine for Locally Advanced Breast Cancer (NCT06949410) | Pravin T.P Kaumaya | 2026-06-01 |
| Reestablishing Normal Gut-brain Interaction in Anorexia Nervose With Normal Gut Microbiota (NCT07574892) | Haukeland University Hospital | 2026-06-01 |
| Engineered Immune Effectors Against Cervical Cancer (NCT03362619) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| GD2/CD70 Bi-specific CAR-T Cell Therapy (NCT05438368) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer (NCT07583160) | Changhai Hospital | 2026-06-01 |
| A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults (NCT07616934) | Vaxcyte, Inc. | 2026-06-01 |
| Exploratory Clinical Trial of DQ1001 in Relapsed or Refractory Multiple Myeloma (RRMM) (NCT07622862) | Zhongshan Hospital (Xiamen), Fudan University | 2026-06-01 |
| Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma (NCT07680569) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2026-06-01 |
| A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy (NCT07137338) | Rocket Pharmaceuticals Inc. | 2026-06-01 |
| Tocilizumab for the Treatment of Refractory Granulomatous Lobular Mastitis (NCT07595900) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-06-01 |
| A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone Deacetylase Inhibitor) in People Living With HIV (NCT07635992) | First Affiliated Hospital of Zhejiang University | 2026-06-01 |
| 4SCAR-T Therapy Post CD19-targeted Immunotherapy (NCT04430530) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Luspatercept for CIA in AML (NCT07663864) | Guangdong Second Provincial General Hospital | 2026-06-01 |
| A Clinical Trial of Multiple Doses of GR2301 Injection in Healthy Adult Trial Participants in China. (NCT07647224) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2026-06-01 |
| A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo (NCT07647237) | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 2026-06-01 |
| TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer (NCT06251544) | Baylor College of Medicine | 2026-06-01 |
| First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect. (NCT07586618) | Allterum Therapeutics, Inc | 2026-06-01 |
| Psychologically Informed Cervicovestibular Rehabilitation (PIC Rehab) for Mild Traumatic Brain Injury: A Feasibility Trial (NCT07402733) | Sport Injury Prevention Research Centre | 2026-06-01 |
| Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute Myeloid Leukemia (NCT07538713) | Qi deng | 2026-06-01 |
| Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer (NCT07495293) | Yonsei University | 2026-06-01 |
| Multi-CAR-T Cells Targeting B Cell Lymphomas (NCT04429438) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Safety and Immunity of Covid-19 aAPC Vaccine (NCT04299724) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Prenatal Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis Clinical Trial (NCT07479953) | Tippi Mackenzie | 2026-06-01 |
| Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis (NCT04085159) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| A Study of KIVU-305 in Participants With Locally Advanced or Metastatic Solid Tumors (NCT07545356) | Kivu Bioscience Inc. | 2026-06-01 |
| Dexamethasone for Ureteral STent Symptoms (DUSTS) (NCT06930690) | The Methodist Hospital Research Institute | 2026-06-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations (NCT07610798) | Shenzhen Ionova Life Sciences Co., Ltd. | 2026-06-01 |
| Stem Cell Mobilization and Apheresis for Life-threatening Blood Disorders (NCT07585136) | St. Jude Children's Research Hospital | 2026-06-01 |
| CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute Leukemia/Malignant Lymphoma (NCT07383233) | Qi deng | 2026-06-01 |
| CM336 for Active Sjogren's Syndrome Study (NCT07642843) | Keymed Biosciences Co.Ltd | 2026-06-01 |
| hAESCs Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation (NCT06444022) | Nanfang Hospital, Southern Medical University | 2026-06-01 |
| Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma (NCT03271632) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Genitourinary Study of Fostering Lactobacillus to Optimize the Microbiome in Women's Health (GUD-FLORA) (NCT07234227) | Duke University | 2026-06-01 |
| Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma (NCT05341947) | Jeremy Rudnick, M.D | 2026-06-01 |
| PSMA-specific CAR-T Cell Therapy (NCT04429451) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety Lead-In for Dosing in Pregnant Women With Severe Pre-eclampsia (NCT07327255) | Evergreen Therapeutics, Inc. | 2026-06-01 |
| WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I) (NCT07615894) | WestVac Biopharma Co., Ltd. | 2026-06-01 |
| The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants (NCT07619885) | Shanghai CureGene Pharmaceutical Co., Ltd. | 2026-06-01 |
| Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors (NCT07612137) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-06-01 |
| HPV Specific Immune Lymphocytes (HPV-CTLs) in the Treatment of HPV (NCT03351855) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| A Phase Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and Lymphoma (NCT07583771) | Chipscreen Biosciences, Ltd. | 2026-06-01 |
| Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease (NCT07455578) | Seismic Therapeutic AU Pty Ltd | 2026-06-01 |
| SKB118 Injection in Advanced Solid Tumors (NCT07586943) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2026-06-01 |
| Universal CAR-T Cells Targeting AML (NCT05995041) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Membrane Potential Mapping with18F-TPP (NCT07506616) | Yale University | 2026-06-01 |
| A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma (NCT07612787) | Centre Hospitalier Universitaire de Saint Etienne | 2026-06-01 |
| A Study of SRSD384 in Overweight or Obese Participants (NCT07557355) | Sirius Therapeutics Co., Ltd. | 2026-06-01 |
| Multi-4SCAR-T Therapy Targeting Breast Cancer (NCT04430595) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Perioperative Zanidatamab and Chemotherapy for HER2 Positive Gastroesophageal Cancer (NCT07477444) | Universitaire Ziekenhuizen KU Leuven | 2026-06-01 |
| Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial) (NCT07166549) | University Hospital, Basel, Switzerland | 2026-06-01 |
| A Multicenter Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia (NCT07595133) | Shanghai 10th People's Hospital | 2026-06-01 |
| Cell Therapy for Lower Limb Ulcers in Patients With Critical Limb Ischemia (NCT06326203) | UPECLIN HC FM Botucatu Unesp | 2026-06-01 |
| Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS (NCT04452097) | Baylx Inc. | 2026-06-01 |
| A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer (NCT06229392) | Rush University Medical Center | 2026-06-01 |
| FEcal tranSplantation in HidradeniTIs suppuratiVA : a piLot Study (NCT07668713) | University Hospital, Clermont-Ferrand | 2026-06-01 |
| Calcium Electroporation for Urinary Bladder Tumors: A First-in-Human Feasibility, Safety, and Early Response Trial (NCT07555769) | Juan Luis Vásquez | 2026-06-01 |
| Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study (NCT07309159) | Centre Hospitalier Charles Perrens, Bordeaux | 2026-06-01 |
| Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer (NCT07652242) | Immunomic Therapeutics, Inc. | 2026-06-01 |
| GAIP ASD Research Study (NCT07622316) | Greater Atlanta Integrative Pediatrics | 2026-06-01 |
| A Study of SSS68 Following a Single Subcutaneous Administration in Healthy Adult Participants (NCT07606976) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2026-06-01 |
| In Vivo CD19/CD20 CAR T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma (NCT07775508) | Chinese PLA General Hospital | 2026-06-01 |
| NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL (NCT05262673) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| A Phase I Study of NS-079 in Healthy Participants (NCT07669571) | NeuShen Therapeutics | 2026-06-01 |
| 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma (NCT04637503) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| A Study of STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) (NCT07428473) | Monash University | 2026-06-01 |
| A Study of CS231295 in Patients With Advanced Solid Tumors (NCT07612488) | ThalassaX Therapeutics United States Ltd | 2026-06-01 |
| Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease (NCT07549698) | CRISPR Therapeutics AG | 2026-06-01 |
| Packed Red Blood Cell Transfusion During Cardiac Arrest (NCT06462027) | NYU Langone Health | 2026-06-01 |
| CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia (NCT07574073) | Qi deng | 2026-06-01 |
| Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma (NCT07316686) | Instituto do Cancer do Estado de São Paulo | 2026-06-01 |
| Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors (NCT07524322) | Regor Pharmaceuticals Inc. | 2026-06-01 |
| Pattern Separation in Major Depressive Disorder (NCT07139834) | Jeffrey Miller | 2026-06-01 |
| CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation (NCT07662369) | Ruijin Hospital | 2026-06-01 |
| BCMA/CD3 Bispecific Antibody as Bridging Therapy Before CAR-T Cell Infusion in RRMM (NCT07407010) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KR25102 in Healthy Volunteers (NCT07618156) | Jiangxi Kvvit Pharmaceutical Co., Ltd. | 2026-06-01 |
| Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD (NCT07224763) | United Therapeutics | 2026-06-01 |
| A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer (NCT07285148) | Beijing Pearl Biotechnology Limited Liability Company | 2026-06-01 |
| Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases (NCT07454668) | Baptist Health South Florida | 2026-06-01 |
| Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST (NCT06735820) | AeRang Kim | 2026-06-01 |
| Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial (NCT07485569) | Radboud University Medical Center | 2026-06-01 |
| PSMA/CD70 Bi-specific CAR-T Cell Therapy (NCT05437341) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Phase I Clinical Study of LNF2105 in Patients With Advanced Solid Tumors (NCT07661797) | Shandong New Time Pharmaceutical Co., LTD | 2026-06-01 |